Nektar Therapeutics | NKTR - Ordinary Share Capital


Nektar Therapeutics reported $20.38M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agios Pharmaceuticals USD 59.34M 892K Mar/2026
ALKERMES USD 165.61M 503K Dec/2025
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Amgen USD 540M 1000K Mar/2026
Baxter International USD 516.45M 2.17M Mar/2026
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cara Therapeutics USD 9.38M 9.38M Sep/2025
Cipla INR 807.77M 807.43M Sep/2025
Dr.Reddys Laboratories INR 832.52M 144K Sep/2025
Eisai JPY 282.11M 1000 Dec/2025
Eli Lilly USD 943.5M 3.33M Mar/2026
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Exelixis USD 262.48M 5.61M Dec/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
Grifols EUR 680.58M 846.11K Dec/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Incyte USD 199.95M 1.49M Mar/2026
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025
MacroGenics USD 63.32M 60K Dec/2025
Merck USD 2.47B 12.72M Dec/2025
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Neurocrine Biosciences USD 100.1M 400K Dec/2025
Novartis USD 1.91B 60K Mar/2026
Pfizer USD 5.69B 0 Dec/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025
Takeda JPY 1.58B 2K Dec/2025
Teva Pharmaceutical Industries USD 1.16B 16.72M Mar/2026
Xencor USD 71.87M 529K Dec/2025